[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20040738L - Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion. - Google Patents

Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion.

Info

Publication number
NO20040738L
NO20040738L NO20040738A NO20040738A NO20040738L NO 20040738 L NO20040738 L NO 20040738L NO 20040738 A NO20040738 A NO 20040738A NO 20040738 A NO20040738 A NO 20040738A NO 20040738 L NO20040738 L NO 20040738L
Authority
NO
Norway
Prior art keywords
ethoxyl
thiazolidine
dione
pyridyl
benzyl
Prior art date
Application number
NO20040738A
Other languages
English (en)
Inventor
Jai Patel
Jeffrey Roger Granett
Paul Nigel Wray
Ross Hamish
Robin Price
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en
Publication of NO20040738L publication Critical patent/NO20040738L/no
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20040738A 1997-06-05 2004-02-20 Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion. NO20040738L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711683.4A GB9711683D0 (en) 1997-06-05 1997-06-05 Composition
GBGB9712851.6A GB9712851D0 (en) 1997-06-18 1997-06-18 Composition
PCT/EP1998/003478 WO1998055122A1 (en) 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
NO20040738L true NO20040738L (no) 2000-02-02

Family

ID=26311662

Family Applications (2)

Application Number Title Priority Date Filing Date
NO995938A NO995938L (no) 1997-06-05 1999-12-03 Blanding omfattende 5-[4-[2-(N-metyl-N-2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion
NO20040738A NO20040738L (no) 1997-06-05 2004-02-20 Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO995938A NO995938L (no) 1997-06-05 1999-12-03 Blanding omfattende 5-[4-[2-(N-metyl-N-2- pyridyl)amino)etoksy]benzyl]tiazolidin-2,4-dion

Country Status (29)

Country Link
EP (1) EP0998284A1 (no)
JP (1) JP2001521553A (no)
KR (1) KR20010013410A (no)
CN (3) CN1112926C (no)
AP (1) AP1214A (no)
AR (2) AR008198A1 (no)
AU (1) AU8215098A (no)
BG (1) BG104048A (no)
BR (1) BR9810405A (no)
CA (2) CA2292629C (no)
CO (1) CO4940400A1 (no)
DZ (1) DZ2510A1 (no)
EA (1) EA002384B1 (no)
GB (1) GB9711683D0 (no)
HU (1) HUP0004070A3 (no)
ID (1) ID24264A (no)
IL (1) IL133074A0 (no)
MX (1) MXPA99011322A (no)
NO (2) NO995938L (no)
NZ (2) NZ523725A (no)
OA (1) OA11306A (no)
PE (1) PE78899A1 (no)
PL (1) PL337201A1 (no)
SK (1) SK164899A3 (no)
TR (2) TR200002790T2 (no)
TW (1) TW570797B (no)
UY (1) UY25032A1 (no)
WO (1) WO1998055122A1 (no)
ZA (2) ZA9811572B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20013800A3 (cs) * 1999-04-23 2002-04-17 Smithkline Beecham Plc Polymorf soli 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]-benzyl]thiazolidin-2,4-dionu s kyselinou maleinovou
DE60004658T2 (de) 1999-04-23 2004-06-24 Smithkline Beecham Plc, Brentford Thiazolidindionderivat und seine verwendung als antidiabetikum
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB0021978D0 (en) 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003050112A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129871D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
DE06252444T8 (de) * 2006-05-09 2009-03-19 Teva Pharmaceutical Industries Ltd. 2-N-{5-[[4-[2-(Methyl-2-pyridinylamino)-ethoxy]-phenyl]-methyl]-2,4-thiazolidindion}-bernsteinsäure, Verfahren zur Herstellung und Zusammensetzungen mit Rosiglitazonmaleat
WO2015008234A1 (en) * 2013-07-17 2015-01-22 Glenmark Pharmaceuticals S.A. Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
CN1083715C (zh) * 1994-02-10 2002-05-01 史密丝克莱恩比彻姆有限公司 胰岛素敏化物治疗肾病的应用
NZ313874A (en) * 1995-08-10 2000-09-29 Warner Lambert Co Compounds used as medicaments useful in eliminating the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
WO1997018811A1 (en) * 1995-11-17 1997-05-29 Warner-Lambert Company A method of treating myotonic dystrophy
IL120443A (en) * 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
CN1230114A (zh) * 1996-07-12 1999-09-29 史密丝克莱恩比彻姆有限公司 Leptine抵抗的新疗法

Also Published As

Publication number Publication date
CA2292629C (en) 2004-01-06
TW570797B (en) 2004-01-11
PE78899A1 (es) 1999-10-22
AR015120A1 (es) 2001-04-18
ZA984826B (en) 1999-08-03
TR200002790T2 (tr) 2001-11-21
WO1998055122A1 (en) 1998-12-10
CN1259050A (zh) 2000-07-05
MXPA99011322A (es) 2004-12-02
GB9711683D0 (en) 1997-08-06
NZ513922A (en) 2001-09-28
NZ523725A (en) 2004-09-24
CA2292629A1 (en) 1998-12-10
EA199901116A1 (ru) 2000-06-26
TR199902963T2 (xx) 2000-02-21
CN1526391A (zh) 2004-09-08
IL133074A0 (en) 2001-03-19
ZA9811572B (en) 1999-07-22
NO995938L (no) 2000-02-02
SK164899A3 (en) 2000-11-07
CN1112926C (zh) 2003-07-02
JP2001521553A (ja) 2001-11-06
CA2333352A1 (en) 1998-12-10
HUP0004070A3 (en) 2002-03-28
NO995938D0 (no) 1999-12-03
AP9901696A0 (en) 1999-12-31
BG104048A (bg) 2000-07-31
CN1430959A (zh) 2003-07-23
CO4940400A1 (es) 2000-07-24
EP0998284A1 (en) 2000-05-10
KR20010013410A (ko) 2001-02-26
AR008198A1 (es) 1999-12-29
DZ2510A1 (fr) 2003-01-25
UY25032A1 (es) 1998-11-26
BR9810405A (pt) 2000-08-29
HUP0004070A2 (hu) 2002-02-28
PL337201A1 (en) 2000-08-14
OA11306A (en) 2003-10-22
AP1214A (en) 2003-10-08
ID24264A (id) 2000-07-13
EA002384B1 (ru) 2002-04-25
AU8215098A (en) 1998-12-21

Similar Documents

Publication Publication Date Title
MA24171A1 (fr) Dihydrates de mesylate de 5- (2- (4-(1,2-benzisothiazole-3-yl) -1-piperazinyl)ethyl) -6-chloro-1,3-dihydro-2h-indole-2-one
FI933804A0 (fi) Monohydrat av 5-(2-(4-(1,2-bensisotiazol-3-yl)-1-piperazinyl)etyl-6-klor-1,3-dihydro-2h-indol-2-onkhydroklorid
TR199800444A3 (tr) Hipolipidemik 1,4-benzotiazepin-1,1-diyoksitler.
DK0996622T3 (da) Hidtil ukendte spiroazabicycliske, heterocykliske forbindelser
NO20040738L (no) Blanding omfattende 5- [4- [2- (N-metyl-N-2-pyridyl])-amino) etoksyl] bensyl] tiazolidin-2,4-dion.
ITTO980715A0 (it) Anima per una tavola scorrevole.
DE69728515D1 (de) Umkehrbare, medienunabhängige Schnittstellenschaltung
CY2004003I2 (el) Παραγωγα 2-(2-αμινο-1, 6-διϋδρο-6-οξο-πυρινο-9-υλο)-μεθοδυ-1,3-προπανεδιολης
NO20003069D0 (no) 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl]tiazolidin- 2,4-dion-maleinsyre-salt-hydrat som farmasøytikum
DE59906902D1 (de) Herbizide 3-(benzo(ox/thi)azol-7-yl)-1h-pyrimidin-2,4-dione
MA25908A1 (fr) Chlorhydrate de 5-(4(2-(n-methyl-n-(2-pyridyl) amino) ethoxy) benzyl)thiazolidine-2,4-dione.
DE69630123D1 (en) Optische spaltung von 1-azabicylo(2.2.2)octan-3-amin,2-(diphenylmethyl)-n-((2-methoxy-5-(1-methylethyl)phenyl)methyl)
ID24639A (id) 2-{3-[4-(2-t-butil-6-trifluorometil-4-pirimidil)-1-piperazinil] propiltio}-4-pirimidinol fumarat
BR9805393B1 (pt) processo para preparar 2-(metiltio)-5-(trifluormetil)-1,3,4-tiadiazol usando metil ditiocarbazinato.
IT1313259B1 (it) Macchina per il montaggio di tomaia e sottopiede di una calzatura.
IT246285Y1 (it) Cerniera.
IL160144A0 (en) Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
TR199801735A3 (tr) 2-(arilfenil)amino-imidazolin türevleri.
TR199700296U (tr) Hasat makinasi.
IT238107Y1 (it) Raviolatrice di affidabile funzionamento
FR2706262B1 (fr) Sac à dos, en particulier pour randonnées.
TR199802196A3 (tr) Heterosiklik bilesimler.
MA25138A1 (fr) 5-(2-ethyl-2h-tatrazole-5-yl)-methyle-1,2,3,6- tetrahydropuridine
TR199802513A3 (tr) N-(4- Karbamimido- fenil)- fenilglisinamid türevleri.
IT1302489B1 (it) Cerniera a doppio scatto per occhiali.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application